Aterian, Inc.

NasdaqCM:ATER Rapport sur les actions

Capitalisation boursière : US$17.1m

Aterian Croissance future

Future contrôle des critères 0/6

Aterian devrait augmenter ses bénéfices et ses revenus de 18.1% et de 1.1% par an respectivement, tandis que le BPA devrait croître de croître de 23.2% par an.

Informations clés

18.1%

Taux de croissance des bénéfices

23.2%

Taux de croissance du BPA

Consumer Durables croissance des bénéfices9.0%
Taux de croissance des recettes1.1%
Rendement futur des capitaux propresn/a
Couverture par les analystes

Low

Dernière mise à jour12 Nov 2024

Mises à jour récentes de la croissance future

Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Nov 15
Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Aterian, Inc. (NASDAQ:ATER) Just Reported, And Analysts Assigned A US$9.67 Price Target

Aug 11
Aterian, Inc. (NASDAQ:ATER) Just Reported, And Analysts Assigned A US$9.67 Price Target

Recent updates

Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Nov 15
Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Is Aterian (NASDAQ:ATER) A Risky Investment?

Oct 15
Is Aterian (NASDAQ:ATER) A Risky Investment?

Aterian, Inc. (NASDAQ:ATER) Just Reported, And Analysts Assigned A US$9.67 Price Target

Aug 11
Aterian, Inc. (NASDAQ:ATER) Just Reported, And Analysts Assigned A US$9.67 Price Target

Aterian, Inc. (NASDAQ:ATER) Surges 42% Yet Its Low P/S Is No Reason For Excitement

Jul 17
Aterian, Inc. (NASDAQ:ATER) Surges 42% Yet Its Low P/S Is No Reason For Excitement

Aterian, Inc.'s (NASDAQ:ATER) Share Price Boosted 30% But Its Business Prospects Need A Lift Too

May 14
Aterian, Inc.'s (NASDAQ:ATER) Share Price Boosted 30% But Its Business Prospects Need A Lift Too

Does Aterian (NASDAQ:ATER) Have A Healthy Balance Sheet?

May 09
Does Aterian (NASDAQ:ATER) Have A Healthy Balance Sheet?

Aterian, Inc. (NASDAQ:ATER) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Feb 27
Aterian, Inc. (NASDAQ:ATER) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Does Aterian (NASDAQ:ATER) Have A Healthy Balance Sheet?

Oct 12
Does Aterian (NASDAQ:ATER) Have A Healthy Balance Sheet?

Things Look Grim For Aterian, Inc. (NASDAQ:ATER) After Today's Downgrade

Aug 14
Things Look Grim For Aterian, Inc. (NASDAQ:ATER) After Today's Downgrade

Is Aterian (NASDAQ:ATER) Weighed On By Its Debt Load?

May 13
Is Aterian (NASDAQ:ATER) Weighed On By Its Debt Load?

Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Mar 12
Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Are Investors Undervaluing Aterian, Inc. (NASDAQ:ATER) By 46%?

Jan 18
Are Investors Undervaluing Aterian, Inc. (NASDAQ:ATER) By 46%?

Aterian gains on guiding Q3 net revenue range above the consensus; resumes M&A strategy

Sep 30

Aterian's Silver Lining

Aug 22

Estimating The Fair Value Of Aterian, Inc. (NASDAQ:ATER)

Aug 17
Estimating The Fair Value Of Aterian, Inc. (NASDAQ:ATER)

Aterian GAAP EPS of -$0.26 misses by $0.08, revenue of $58.27M misses by $1.34M

Aug 08

Is Aterian (NASDAQ:ATER) Using Too Much Debt?

Jul 28
Is Aterian (NASDAQ:ATER) Using Too Much Debt?

Should You Think About Buying Aterian, Inc. (NASDAQ:ATER) Now?

Jul 08
Should You Think About Buying Aterian, Inc. (NASDAQ:ATER) Now?

Prévisions de croissance des bénéfices et des revenus

NasdaqCM:ATER - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/2026108-12N/AN/A1
12/31/2025103-13-4-43
12/31/202498-14-1-13
9/30/2024107-18-3-3N/A
6/30/2024121-23-2-2N/A
3/31/2024128-54-6-6N/A
12/31/2023143-75-14-13N/A
9/30/2023165-87-7-6N/A
6/30/2023191-198-4-4N/A
3/31/2023214-179-12-12N/A
12/31/2022221-196-18-17N/A
9/30/2022230-183-21-21N/A
6/30/2022231-176-31-31N/A
3/31/2022241-196-47-47N/A
12/31/2021248-236-42-42N/A
9/30/2021226-274-42-42N/A
6/30/2021217-164-18-18N/A
3/31/2021208-1311515N/A
12/31/2020186-6366N/A
9/30/2020170-37-5-4N/A
6/30/2020152-51-18-18N/A
3/31/2020122-65-30-30N/A
12/31/2019114-59-25-25N/A
9/30/2019109-49-24-24N/A
6/30/201993-39-29-29N/A
3/31/201977-31-33-33N/A
12/31/201873-32-30-30N/A
12/31/201736-23N/A-29N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: ATER devrait rester non rentable au cours des 3 prochaines années.

Bénéfices vs marché: ATER devrait rester non rentable au cours des 3 prochaines années.

Croissance élevée des bénéfices: ATER devrait rester non rentable au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de ATER ( 1.1% par an) devrait croître plus lentement que le marché de US ( 9% par an).

Croissance élevée des revenus: Le chiffre d'affaires de ATER ( 1.1% par an) devrait croître plus lentement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de ATER devrait être élevé dans 3 ans


Découvrir les entreprises en croissance